AI assistant
Sending…
AVIENT CORP — Director's Dealing 2024
Dec 13, 2024
31389_dirs_2024-12-13_630b9ca6-6781-4d60-be3d-8275211fcd6e.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: AVIENT CORP (AVNT)
CIK: 0001122976
Period of Report: 2024-12-11
Reporting Person: Moh Woon Keat (SVP, President CAI Asia & Amer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2024-12-11 | Common Stock | M | 1250 | $38.27 | Acquired | 12040 | Direct |
| 2024-12-11 | Common Stock | F | 1121 | $49.27 | Disposed | 10919 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2024-12-11 | Stock Appreciation Rights | $38.27 | M | 1250 | Disposed | 2025-02-04 | Common Stock (1250) | Direct |
Footnotes
F1: Includes dividend equivalents earned with respect to the vested restricted stock units.
F2: SARs become exercisable and vest only upon the achievement of both price and time requirements. To vest, each one-third of the grant must attain 10%, 15% and 20% stock appreciation, respectively (which must be maintained for a minimum of thirty consecutive trading days) from the grant date closing price of $38.27 per share and no more than one-third of the grant can vest per year during the first three years.
More from AVIENT CORP
Regulatory Filings
2026
May 15
Interim / Quarterly Report
2026
May 7
Regulatory Filings
2026
May 7
Regulatory Filings
2026
Apr 27
Annual Report
2026
Mar 27
Regulatory Filings
2026
Mar 27
Proxy Solicitation & Information Statement
2026
Mar 27
Director's Dealing
2026
Feb 24
Director's Dealing
2026
Feb 24
Director's Dealing
2026
Feb 24